Table 3. Factors associated with sustained virological response.
| Factors | SVR (n = 176) | Non-SVR (n = 9) | p-value | |
|---|---|---|---|---|
| Gender | Male | 119 (96.0) | 5 (4.0) | 0.480 |
| Female | 57(93.4) | 4 (6.6) | ||
| Age | ≤65 | 156 (95.1) | 8 (4.9) | 1.000 |
| >65 | 20 (95.2) | 1 (4.8) | ||
| BMI | <25 | 70 (97.2) | 2 (2.8) | 0.486 |
| ≥25 | 106 (93.8) | 7 (6.2) | ||
| Liver fibrosis stage | Non-cirrhosis | 74 (98.7) | 1 (1.3) | 0.086 |
| Cirrhosis | 102 (92.7) | 8 (7.3) | ||
| Genotype | 1 | 73 (98.6) | 1 (1.4) | 0.001* |
| 3 | 69 (98.6) | 1 (1.4) | ||
| 6 | 34 (82.9) | 7 (17.1) | ||
| Viral load | Low | 152 (95.0) | 8 (5.0) | 1.000 |
| High | 24 (96.0) | 1 (4.0) | ||
| Prior treatment history | Naïve | 145 (96.7) | 5 (3.3) | 0.067 |
| Experienced | 31 (88.6) | 4 (11.4) |
SVR: Sustained virological response; BMI: Body mass index.